Palvella Therapeutics (PVLA) Cash & Equivalents (2013 - 2026)
Palvella Therapeutics' Cash & Equivalents came in at $187.8 million for Q2 2026, up 166.6% from $70.43 million a year earlier but down 9.0% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Palvella Therapeutics' Cash & Equivalents was $57.98 million, down 30.6% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -3.8% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $83.6 million in FY2024, $7.35 million in FY2023 (-81.0%), $38.64 million in FY2022 (-67.2%) and $117.76 million in FY2021 (+67.2%).
- The five-year range for quarterly Cash & Equivalents is $6.25 million (Q1 2024) to $206.39 million (Q1 2026).
- Year-over-year, Cash & Equivalents increased in four of the last six quarters, with growth averaging 164.0%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2025 (growth of 384.5%), and the weakest in Q1 2024 (a decline of 84.3%).
- Business Quant data shows PVLA's Cash & Equivalents at $206.39 million (Q1 2026), $57.98 million (Q4 2025) and $63.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Palvella Therapeutics | 1.91 Bn | 1.66 Bn | - | 187.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 187.80 Mn |
| Mar 31, 2026 | 206.39 Mn |
| Dec 31, 2025 | 57.98 Mn |
| Sep 30, 2025 | 63.57 Mn |
| Jun 30, 2025 | 70.43 Mn |
| Mar 31, 2025 | 75.63 Mn |
| Dec 31, 2024 | 83.60 Mn |
| Sep 30, 2024 | 14.21 Mn |
| Jun 30, 2024 | 14.54 Mn |
| Mar 31, 2024 | 6.25 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Sep 30, 2023 | 32.89 Mn |
| Jun 30, 2023 | 44.94 Mn |
| Mar 31, 2023 | 39.74 Mn |
| Dec 31, 2022 | 38.64 Mn |
| Sep 30, 2022 | 48.42 Mn |
| Jun 30, 2022 | 54.26 Mn |
| Mar 31, 2022 | 83.74 Mn |
| Dec 31, 2021 | 117.76 Mn |
| Sep 30, 2021 | 125.05 Mn |
API Access
Palvella Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();